Acupuncture to Prevent Postoperative Bowel Paralysis (Paralytic Ileus)

Neoplasms Clinical Trial

Official title:

Acupuncture to Prevent Postoperative Paralytic Ileus

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT00065234
• Other study ID #: R21AT001065-01A1
• Secondary ID: ChiangJ
• Status: Terminated
• Phase: Phase 2
• First received: July 18, 2003
• Last updated: March 27, 2017
• Start date: September 2003
• Est. completion date: May 2006

Study information

• Verified date: March 2017
• Source: National Center for Complementary and Integrative Health (NCCIH)
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to determine if acupuncture is effective in preventing prolonged postoperative paralysis of the gastrointestinal tract among patients undergoing colostomy/ileostomy closure.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 100
• Est. completion date: May 2006
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Previous surgical cancer treatment with ileostomy/colostomy, now scheduled for closure

• Hospital admission must be same day as surgery

Exclusion Criteria:

• Incapacitating disease

• Concurrent herbal or laxative use

• Use of Heparin or Coumadin

• Upper or lower extremity deformities

• Chronic constipation prior to cancer diagnosis

• History of cerebrovascular accident or spinal cord injury

• Chronic pain that has been treated with any form of major opioid or weak opioids (=/> 30mg/24 hours)

• Pacemaker or metal implants

• Concurrent alternative medicine/herbal use

Related Conditions & MeSH terms

• Ileus
• Intestinal Pseudo-Obstruction
• Neoplasms

Intervention

Procedure:
• Acupuncture

Locations

Country	Name	City	State
United States	MD Anderson Cancer Center	Houston	Texas

Sponsors (1)

Lead Sponsor	Collaborator
National Center for Complementary and Integrative Health (NCCIH)

Country where clinical trial is conducted

United States,